Literature DB >> 20536560

Non-cytotoxic antiviral activities of granzymes in the context of the immune antiviral state.

Felipe Andrade1.   

Abstract

Viruses are obligatory intracellular parasites, whose replication depends on components encoded by the virus and pathways and functions of the host cell. In addition to the pathways required for viral synthesis, viruses activate multiple mechanisms to evade immune attack, promoting viral propagation while avoiding or slowing the host immune response. To achieve efficient control of viral infections, the immune system in vertebrates relies on diverse and synergistic antiviral pathways (both at the innate and adaptive immune response), which target and inactivate viral and host components involved both in viral replication and in viral defenses that block host antiviral activities. During this process, the immune system uses mechanisms to slow down viral propagation, while apoptotic pathways are triggered to kill (when possible) the infected cell. Granzymes (granule enzymes) are key components of the immune response that play important roles in eliminating host cells infected by intracellular pathogens. Although the induction of target cell death has been considered the central function for these proteases, recent evidence supports that granzymes can achieve direct antiviral activities through the cleavage of viral and host factors required for viral replication and viral defense. In addition, granzyme A can stimulate the production of pro-inflammatory cytokines. The focus of this review is to discuss recent views on antiviral mechanisms involved in controlling viral infections, with special interest in novel and potential non-death-related antiviral functions of the granzymes, and how these unique functions complement and synergize with the 'antiviral state' created by interferons and cytotoxic lymphocytes in response to virus.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20536560     DOI: 10.1111/j.0105-2896.2010.00909.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  26 in total

1.  Hepatitis B virus inhibits the expression of complement C3 and C4, in vitro and in vivo.

Authors:  Chengliang Zhu; Hui Song; Fengxia Xu; Wei Yi; Fang Liu; Xinghui Liu
Journal:  Oncol Lett       Date:  2018-03-09       Impact factor: 2.967

Review 2.  The CD8+ T Cell Noncytotoxic Antiviral Responses.

Authors:  Maelig G Morvan; Fernando C Teque; Christopher P Locher; Jay A Levy
Journal:  Microbiol Mol Biol Rev       Date:  2021-05-12       Impact factor: 11.056

Review 3.  Perforin and granzymes: function, dysfunction and human pathology.

Authors:  Ilia Voskoboinik; James C Whisstock; Joseph A Trapani
Journal:  Nat Rev Immunol       Date:  2015-06       Impact factor: 53.106

4.  Granzyme K-deficient mice show no evidence of impaired antiviral immunity.

Authors:  Lars T Joeckel; Cody C Allison; Marc Pellegrini; Catherina H Bird; Phillip I Bird
Journal:  Immunol Cell Biol       Date:  2017-04-21       Impact factor: 5.126

5.  Serine protease inhibition attenuates rIL-12-induced GZMA activity and proinflammatory events by modulating the Th2 profile from estrogen-treated mice.

Authors:  Ebru Karpuzoglu; Chad W Schmiedt; Julian Pardo; Megan Hansen; Tai L Guo; Steven D Holladay; Robert M Gogal
Journal:  Endocrinology       Date:  2014-05-19       Impact factor: 4.736

6.  TOE1 is an inhibitor of HIV-1 replication with cell-penetrating capability.

Authors:  Sabina Sperandio; Corinne Barat; Miguel A Cabrita; Ana Gargaun; Maxim V Berezovski; Michel J Tremblay; Ian de Belle
Journal:  Proc Natl Acad Sci U S A       Date:  2015-06-08       Impact factor: 11.205

7.  Postexposure treatment with the live-attenuated rabies virus (RV) vaccine TriGAS triggers the clearance of wild-type RV from the Central Nervous System (CNS) through the rapid induction of genes relevant to adaptive immunity in CNS tissues.

Authors:  Jianwei Li; Adam Ertel; Carla Portocarrero; Darryll A Barkhouse; Bernhard Dietzschold; D Craig Hooper; Milosz Faber
Journal:  J Virol       Date:  2012-01-11       Impact factor: 5.103

8.  A pro-survival role for the intracellular granzyme B inhibitor Serpinb9 in natural killer cells during poxvirus infection.

Authors:  Matthew S Mangan; Carolina R Melo-Silva; Jennii Luu; Catherina H Bird; Aulikki Koskinen; Alexandra Rizzitelli; Monica Prakash; Katrina L Scarff; Arno Müllbacher; Matthias Regner; Phillip I Bird
Journal:  Immunol Cell Biol       Date:  2017-08-15       Impact factor: 5.126

9.  Dermal-resident versus recruited γδ T cell response to cutaneous vaccinia virus infection.

Authors:  Amanda S Woodward Davis; Tessa Bergsbaken; Martha A Delaney; Michael J Bevan
Journal:  J Immunol       Date:  2015-01-21       Impact factor: 5.422

10.  Why do human B cells secrete granzyme B? Insights into a novel B-cell differentiation pathway.

Authors:  Magdalena Hagn; Bernd Jahrsdörfer
Journal:  Oncoimmunology       Date:  2012-11-01       Impact factor: 8.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.